A Panel of CA19-9, Ca125, and Ca15-3 as the Enhanced Test for the Differential Diagnosis of the Pancreatic Lesion

Background. Proper diagnosis of pancreatic lesion etiology is a challenging clinical dilemma. Studies suggest that surgery for suspected pancreatic ductal adenocarcinoma (PDAC) reveals a benign lesion in 5% to 13% of cases. The aim of our study was to assess whether routinely used biomarkers such as...

Descripción completa

Detalles Bibliográficos
Autores principales: Hogendorf, Piotr, Skulimowski, Aleksander, Durczyński, Adam, Kumor, Anna, Poznańska, Grażyna, Oleśna, Aleksandra, Rut, Joanna, Strzelczyk, Janusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357521/
https://www.ncbi.nlm.nih.gov/pubmed/28356610
http://dx.doi.org/10.1155/2017/8629712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357521/
https://www.ncbi.nlm.nih.gov/pubmed/28356610
http://dx.doi.org/10.1155/2017/8629712

Ejemplares similares